electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference
ROCKAWAY, N.J., April 08, 2026 -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham Virtual Healthcare Conference taking place virtually on April 15, 2026.
Joshua Lev, Interim President and Chief Financial Officer, will host a company presentation at 2:15 pm ET and participate in one-on-one meetings throughout the day.
DATE: April 15, 2026
TIME: 2:15 pm ET
About electroCore, Inc.
electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hindalco misses profit estimates as Novelis disruptions weigh
Congress Revives US Bitcoin Reserve Idea – With a 20-Year Hold
Dow Jones Industrial Average shrugs off a hawkish new Fed chair to set a record
Black Swan Capitalist: What Will Trigger XRP Repricing Revealed
Trending news
MoreCrypto prices
More
